Hua Medicine | Sustainability Performance
Develops pharmaceutical products targeting metabolic diseases.
2011
China
51 - 200 employees
Pharmaceuticals
$25M - 100M in revenue
N/A in profitability
Sustainability Ranking & Industry Benchmark
#11559
Overall#710
in China#276
in PharmaceuticalsSustainability Maturity
Sustainability Intent
Overview
Governance
TargetsESG scores and ExclusionsFinancial Data
Business performanceCapital & innovationAnalyst projections
Market cap
Revenue
R&D intensity
Controversy level
- JKX Oil & Gas' operations carry environmental contamination and spill risks.
Market cap
Revenue
EBITDA
Operating margin
P/E ratio
Revenue & EBITDA
$255.0MFY2024 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
R&D intensity
84.3%FY2024
R&D as % of revenue
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Return on invested capital
-152.0%FY2026
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
0.0
▼ 94.1%
0.1
▼ 49.7%
0.3
▼ 53.6%
6.7
2026Powered by illuminem
Environmental policy coverage
Carbon reduction policy
Not available
Human rights policy
Available
Recycling policy
Available
Workplace health & safety policy
Available
20%
Independent Directors
3 out of 15 incl. management
Overall score
49
Environment
64
Social
38
Governance
47
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Not available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
